Clinical strategies for the alleviation of contractures from a predictive mathematical model of dermal repair

Wound Repair and Regeneration

Volumn 20, Issue 2, 2012, Pages 194-202

  Murphy, Kelly E ^a   McCue, Scott W ^a   McElwain, D L Sean ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BURN CONTRACTURE; COLLAGEN SYNTHESIS; DERMIS; HYPERTROPHIC SCAR; INFLAMMATION; MATHEMATICAL MODEL; MYOFIBROBLAST; PREDICTION; PRIORITY JOURNAL; SKIN SCAR; WOUND CONTRACTION; WOUND HEALING;

ANIMALS; APOPTOSIS; CICATRIX, HYPERTROPHIC; COLLAGEN; CONTRACTURE; HUMANS; MICE; MODELS, THEORETICAL; MYOFIBROBLASTS; PREDICTIVE VALUE OF TESTS; RATS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; WOUND HEALING;

EID: 84858133336     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00775.x     Document Type: Article

References (40)

1. Enoch S, Leaper DJ,. Basic science of wound healing. Surgery 2007; 26: 31-37. (Pubitemid 351242557)
2. Bloemen MC, van der Veer WM, Ulrich MM, van, Zuijlen PP, Niessen FB, Middelkoop E,. Prevention and curative management of hypertrophic scar formation. Burns 2009; 35: 463-475.
3. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, Holmes JW, Longaker MT, Yee H, Gurtner GC,. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007; 21: 3250-3261. (Pubitemid 47565543)
4. Kose O, Waseem A,. Keloids and hypertrophic scars: are they two different sides of the same coin? Dermatol Surg 2008; 34: 336-346. (Pubitemid 351316825)
5. Hinz B,. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007; 127: 526-537.
6. Varga J, Abraham D,. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117: 557-567. (Pubitemid 46348510)
7. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmouliere A,. Mechanisms of pathological scaring: role of myofibroblasts and current developments. Wound Rep Regen 2011; 19: S10-S15.
8. Linge C, Richardson J, Vigor C, Clayton E, Hardas B,. Hypertrophic scar cells fail to undergo a form of apoptosis specific to contractile collagen-the role of tissue transglutaminase. J Invest Dermatol 2005; 125: 72-82. (Pubitemid 40981426)
9. Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G,. TGF-beta and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 2009; 1792: 746-756.
10. Ferguson MW, O'Kane S,. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-850. (Pubitemid 38673751)
11. Franz MG, Steed DL, Robson MC,. Optimizing healing of the acute wound by minimizing complications. Curr Probl Surg 2007; 44: 691-763. (Pubitemid 350129811)
12. Occleston NL, Laverty HG, O'Kane S, Ferguson MW,. Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 2008; 19: 1047-1063. (Pubitemid 351957390)
13. Ferguson MW, Duncan J, Bond J, Bush J, Durani P, So K, Chantrey J, Mason T, James G, Laverty H, Occleston NL, Sattar A, Ludlow A, O'Kane S,. Prophylactic administration of avotermin for improvement of skin scaring: three double-blind, placebo-controlled, phase I/II studies. Lancet 2009; 373: 1264-1274.
14. Wynn TA,. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210. (Pubitemid 351160157)
15. Douglass A, Wallace K, Koruth M, Barelle C, Porter AJ, Wright MC,. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol Int 2008; 2: 405-415.
16. Mizuno S, Matsumoto K, Li M-Y, Nakamura T,. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. FASEB J 2005; 19: 580-582. (Pubitemid 40471250)
17. Pines M,. Targeting TGF β signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone. Expert Opin Drug Discov 2008; 3: 11-20. (Pubitemid 351188342)
18. Viera MH, Aminia S, Valines W, Berman B,. Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol 2010; 3: 20-26.
19. Murphy KE, Hall CL, McCue SW, McElwain DL,. A two-compartment mechanochemical model of the roles of transforming growth factor and tissue tension in dermal wound healing. J Theor Biol 2011; 272: 145-159.
20. McGrath MH, Simon RH,. Wound geometry and the kinetics of wound contraction. Plast Reconstr Surg 1983; 72: 66-72. (Pubitemid 13068429)
21. Cook J,. A mathematical model for dermal wound healing: wound contraction and scar formation. PhD thesis, University of Washingston, 1995.
22. Hall CL,. Modelling of some biological materials using continuum mechanics. PhD thesis, Queensland University of Technology, 2009.
23. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA,. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-363. (Pubitemid 34619269)
24. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Valle CA, Roy M,. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 2004; 198: 350-358. (Pubitemid 38235030)
25. Farahani RM, Kloth LC,. The hypothesis of "biophysical matrix contraction": wound contraction revisited. Int Wound J 2008; 5: 477-482. (Pubitemid 351877043)
26. Akasaka Y, Ono I, Kamiya T, Ishikawa Y, Kinoshita T, Ishiguro S, Yokoo T, Imaizumi R, Inomata N, Fujita K, Akishima-Fukasawa Y, Uzuki M, Ito K, Ishii T,. The mechanisms underlying fibroblast apoptosis regulated by growth factors during wound healing. J Pathol 2010; 221: 285-299.
27. Tiede S, Ernst N, Bayat A, Paus R,. Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Ann Anat 2009; 191: 33-44.
28. Varga J, Pasche B,. Transforming growth factor as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 2009; 5: 200-206.
29. Liu W, Wu X, Gao Z,. New potential antiscarring approaches. Wound Rep Regen 2011; 19: S22-S31.
30. Shah M, Foremand DM, Ferguson MW,. Neutralising antibody to TGF-beta 1 and TGF-beta 2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994; 107: 1137-1157.
31. Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA,. The temporal effects of anti-TGF-beta1, 2 and 3 monocolonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 2005; 201: 391-397. (Pubitemid 41206777)
32. Yang L, Qiu CX, Ludlow A, Ferguson MW, Brunner G,. Active transforming growth factor-beta in wound repair: determination using a new assay. Am J Pathol 1999; 154: 105-111. (Pubitemid 29031617)
33. Greenhalgh DG,. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998; 30: 1019-1030. (Pubitemid 28484857)
34. Atiyeh BS, Costagliola M,. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns 2007; 33: 405-413. (Pubitemid 46702394)
35. Phan SH,. The myofibroblast in pulmonary fibrosis. Chest 2002; 122: 286S-289. (Pubitemid 36043014)
36. 1. BMC Dermatol 2002; 2: 13.
37. Cubison TC, Pape SA, Parkhouse N,. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald. Burns 2006; 32: 992-999. (Pubitemid 44647539)
38. Zuber TJ,. The mattress sutures: vertical, horizontal, and corner stitch. Am Fam Physician 2002; 66: 2231-2236. (Pubitemid 36193495)
39. Lloyd JD, Marque MJ III, Kacprowicz RF,. Closure techniques. Emerg Med Clin North Am 2007; 25: 73-81. (Pubitemid 46509559)
40. Friedman A,. What is mathematical biology and how useful is it? Notices of the AMS 2010; 57: 851-857.